Bio-Rad Laboratories operates through two primary business segments: Life Science and Clinical Diagnostics. The Life Science segment develops and manufactures instruments, reagents, and consumables used by universities, pharmaceutical companies, and research institutes to characterize and quantify biological materials like proteins and nucleic acids. The Clinical Diagnostics segment designs and supports test systems, informatics solutions, and specialized quality controls for hospital and reference laboratories, with strong positions in blood virus testing, immunohematology, and diabetes monitoring. The company maintains a significant global footprint, generating more than half of its revenue from international markets across Europe, Asia, and the Americas. Bio-Rad's competitive position is bolstered by its recurring revenue model, where the initial sale of laboratory instruments drives ongoing purchases of proprietary consumables, test kits, and reagents.
